-
Stopping Aspirin Before Surgery; The Sponge Returns; Preventing Metabolic Syndrome; FDA Actions.
-
-
-
Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor and has documented single-agent activity in patients with recurrent ovarian cancer.
-
As a way to indirectly investigate the effects of lubricating products used by infertile women during intercourse on sperm quality, semen from 22 normospermic men was tested against several common lubricants (Pre-Seed®, Astroglide®, K-Y® Sensitive®, K-Y® Warming®, and K-Y® Tingling) and natural oils (baby, canola, sesame, and mustard) at 0, 5, 30 and 60 minutes.
-
A study that has focused on patients who are exposed to second-hand smoke shows a higher rate of preeclampsia than nonsmokers.
-
This randomized, controlled trial demonstrates that women are able to self-administer subcutaneous depot medroxyprogesterone acetate at home correctly and without complication.
-
Almost all of the women who elected to continue use of a levonorgestrel intrauterine system by replacement after the first 5-year interval had favorable bleeding patterns during the second 5 years of use, with almost half experiencing amenorrhea.
-
The authors performed a nested case-control study using data from the Rochester Epidemiology Project which conducts population-based studies of the residents of Olmsted County, Minnesota.
-
In this issue: Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
